ENDOMETRIOZLARNI IMMUNOGISTOKIMYOVIY O’ZGARISHLARI TAVSIFI

TO'LIQ MATN:

Abstrakt

Endometriozni etio-patogenezini o’rganishda eutopik va ektopik endometriyaning molekulyar-biologik o’ziga xosligi – esterogen va progestoron resteptorlarini ekspressiyasi, proliferastiyasi, apoptozi, adgeziyasi, angiogenezi, hujayra invaziyasi markerlarini o’rganish perspektiv yo’nalishlardan hisoblanadi. Ishning maqsadi:  Reproduktiv yoshdagi ayollarda  boshqa ginekologik patologiyalarsiz xayz davrining proliferativ bosqichidagi adenomioz va tuhumdon endometriozidagi molekulyar-biologik xususiyatlarini o’rganish. Material va uslublar:  Ushbu tadqiqotda 2019-2022 yillar mobaynida gisterektomiya qilingan menopauzagacha (18-51yosh 60-ta bioptat) va postmenopauza davridagi ayollar bioptatlariga (51 va undan katta yoshdagilar, 20-ta bioptat) immunogistokimyoviy usullarda tekshirildi. Ushbu tadqiqotda  2019-22 yilda AVPAB tekshirilgan 80ta adenomioz va tuhumdonlar endometriozlari bioptatlarini immunogistokimyoviy tekshiruvida estrogen va progesteron gormonal faoliyatni buzilishi 60-90% holatlarda progesteron,  50-70% holatlarda estrogen gormoni bachadon adenomiozi  rivojlanishda va bachadonning bezli giperplaziyasiga olib kelishi, buni natijasida bemorlarda bachadon endometriysini atipik rivojlanishi va xavfli o’sma kasalligiga o’tishi kuzatildi. Ki-67  va  r53 postmenopauzada davridagi 20% bemorlarda bachadonning boshlang’ich yomon sifatli o’sma holatiga o’tganligi bilan namoyon bo’ldi.

Mualliflar haqida

Adabiyotlar ro'yxati

Adamyan L.V. et al. The role of proliferation processes in the pathogenesis of endometriosis. Reproduction problems.Technologies of the XXI century in gynecology. Спец Выпуск-М 2008:82.

Zairatiants O.V. et al. The role of apoptosis and proliferation in the pathogenesis of simple and proliferating uterine fibroids in combination with adenomyosis / In the book. Uterine fibroids. Edited by corresponding member of the Russian Academy of Sciences Sidorova I.S. M: “MIA” 2002:113–27.

Voloshchuk et al. Molecular biological aspects of the pathogenesis of adenomyosis. Pathology Archive 2007:56–61.

Sidorova I.S. et al. Molecular and biological features of endometriosis, pathogenetically justified therapy pathways. Abstracts of the reports of the Russian Medical Forum-2006 “Fundamental science and Practice”-M 2006:128.

Kogan E.A. et al. Clinical and morphological parallels and molecular aspects of adenomyosis morphogenesis. Archive of pathology 2008:8–12.

Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999;94:71–7. https://doi.org/10.1016/s0029-7844(99)00279-3.

KitawakiJ. et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acidin human endometriotic and adenomyotic tissues bu tnotin normal endometrium. Biol Reprod 1997;57:514–9.

Schmidt С. Endometriosis: Pathogenesis and Treatment. Fertil Steril 1990;53:407–10.

Qanday qilib iqtibos keltirish kerak

Karimjonov, X., & Mamataliyev , A. . (2023). ENDOMETRIOZLARNI IMMUNOGISTOKIMYOVIY O’ZGARISHLARI TAVSIFI . Xalqaro Ilmiy Pediatriya Jurnali, 2(3), 121–127. https://doi.org/10.56121/2181-2926-2023-2-3-121-127
Ko'rishlar soni: 59

Ushbu muallif(lar)ning eng koʻp oʻqilgan maqolalari